NASDAQ · Shell Companies · USD

Cantor Equity Partners VII, Inc. (CAES) Stock Analysis

Cantor Equity Partners VII, Inc. (CAES) is a Shell Companies stock listed on NASDAQ and quoted in US Dollar.

Last Updated: October 22, 2026

CAES

$10.00

+$0.01 (+0.05%)

Oct 22, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare CAES with… →

CAES Key Statistics

As of Oct 22, 2026

Trading

Open: $10.00
Previous Close: $10.00
Day's Range: 10.00–10.01
52-Week Range: 10.01–10.17
Volume: 6.86K

Valuation

Market Cap: $318.82M

Financials (FY)

Revenue (FY): $0.00
Net Income (FY): −$63.26K
Shares Outstanding: 25.60M

Dividend and dates

Avg Volume: 29.87K

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

Key facts

Cantor Equity Partners VII, Inc. (CAES) has a market capitalization of $318.82M.

In fiscal 2025, CAES reported revenue of $0.00.

CAES Revenue and Earnings by Fiscal Year

FY ends December

RevenueNet income

202320242025

Fiscal year	Revenue	Net income	Net margin
2025	$0.00	−$63.26K	—
2024	$0.00	−$4.17K	—
2023	$0.00	−$3.47K	—

Fiscal year	Revenue	Gross profit	Operating income	Net income	Net margin
2025	$0.00	—	−$63.26K	−$63.26K	—
2024	$0.00	—	−$4.17K	−$4.17K	—
2023	$0.00	—	−$3.47K	−$3.47K	—

Annual figures as reported, in the company's reporting currency. As of December 31, 2025.

Analysis

Data-derived

Company Overview

Cantor Equity Partners VII, Inc. (CAES) is capitalised at $318.82M on the latest close. It is classified in the Shell Companies industry, within the Financial Services sector.

CAES last closed at $10.00 on October 22, 2026. That is +$0.01 (+0.05%) against the previous close. The 52-week range on file runs from $10.01 to $10.17.

Financial Health

The most recent full year on file, fiscal 2025, shows revenue of $0.00. The same year closed with a net loss of $63.26K.

Across the 3 fiscal years on file, revenue moves from $0.00 in 2023 to $0.00 in 2025. Of those 3 years, 0 report positive net income.

Growth & Income

The record shows no dividend for CAES.

So far in 2026 the total return is −1.09%.

Peer Comparison

Cantor Equity Partners VII, Inc. (CAES) operates in the Shell Companies industry. Here is how it compares to its closest peers by market capitalization:

Company	Ticker	Market Cap	P/E Ratio
Cantor Equity Partners VII, Inc.	CAES	$318.82M	—
Vylor Inc.	VYLR	$47.46B	101.6
Drugs Made In America Acquisition II Corp.	DMII	$649.10M	34.0
Churchill Capital Corp XI	CCXI	$621.61M	—

Every figure above is read from this page's own data on each daily rebuild. Informational only, not financial advice. As of October 22, 2026.

Related Shell Companies Stocks

VYLR

Vylor Inc.

$47.46B

DMII

Drugs Made In America Acquisition II Corp.

$649.10M

CCXI

Churchill Capital Corp XI

$621.61M

EVAC

EQV Ventures Acquisition Corp. II

$603.77M

BCSS

Bain Capital GSS Investment Corp.

$595.97M

CEPF

Cantor Equity Partners IV, Inc.

$587.79M

View all Shell Companies stocks →

Popular Financial Services Stocks

BRK-B

Berkshire Hathaway Inc.

$1.11T

JPM

JPMorgan Chase & Co.

$893.72B

Visa Inc.

$777.86B

Mastercard Incorporated

$554.70B

BAC

Bank of America Corporation

$357.19B

View all Financial Services stocks →

About Cantor Equity Partners VII, Inc.

Cantor Equity Partners VII, Inc. focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company was formerly known as CF International Acquisition Corp. IX and changed its name to Cantor Equity Partners VII, Inc. in August 2025. Cantor Equity Partners VII, Inc. was incorporated in 2021 and is headquartered in New York, New York.